跳至主要内容
临床试验/JPRN-UMIN000023448
JPRN-UMIN000023448已完成未知

Impact of lipid-lowering therapy with Evolocumab on coronary plaque regression in patients with coronary artery disease - Impact of Evolocumab on coronary plaque regression

Chiba University Graduate School of Medicine0 个研究点目标入组 3 人开始时间: 2016年8月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Difficulty to observe the coronary arteries, including non-culprit lesions, by IVUS at PCI procedure 2) Severe hepatic insufficiency 3) Severe renal insufficiency 4) Severe heart failure (left ventricular ejection fraction <30%, or NYHA class III or IV) 5) intolerance or allergy to statin 6) Pregnant, postpartum within 28 days, or breast-feeding 7) Recognized as inadequate by attending doctor

研究者

发起方
Chiba University Graduate School of Medicine

相似试验